- testing |
Sector
PharmaceuticalsOpen
₹30.9Prev. Close
₹29.49Turnover(Lac.)
₹0.29Day's High
₹30.9Day's Low
₹29.4952 Week's High
₹64.7552 Week's Low
₹23.6Book Value
₹6.58Face Value
₹10Mkt Cap (₹ Cr.)
21.09P/E
0EPS
0Divi. Yield
023 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
30 Aug 2024
12:00 AM
AGM
Announcement Date: 30 Aug, 2024
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 6.83 | 6.83 | 6.83 | 6.83 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 3.47 | 3.98 | 5.23 | 6.83 |
Net Worth | 10.3 | 10.81 | 12.06 | 13.66 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 19.89 | 24.45 | 20.17 | 14.35 |
yoy growth (%) | -18.64 | 21.18 | 40.52 | -33.54 |
Raw materials | -14.57 | -17.79 | -10.85 | -6.73 |
As % of sales | 73.27 | 72.76 | 53.78 | 46.88 |
Employee costs | -1.49 | -1.58 | -1.81 | -1.54 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 0.47 | 0.96 | 0.67 | 0.26 |
Depreciation | -0.34 | -0.39 | -0.46 | -0.44 |
Tax paid | -0.16 | -0.42 | -0.1 | -0.1 |
Working capital | 0.19 | 2.02 | 0.06 | 0.41 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -18.64 | 21.18 | 40.52 | -33.54 |
Op profit growth | -107.56 | 24.37 | 397.72 | -39.1 |
EBIT growth | -50.83 | 38.23 | 162.62 | 7.53 |
Net profit growth | -42.2 | -5.76 | 252.55 | 289.14 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,688.25 | 94.58 | 4,05,067.73 | 2,000.46 | 0.95 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,671.4 | 80.18 | 1,77,104.71 | 667 | 0.45 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,510.65 | 24.77 | 1,22,013.74 | 1,485.4 | 1.06 | 4,254.47 | 397.42 |
Dr Reddys Laboratories Ltd DRREDDY | 1,349.9 | 21.06 | 1,12,643.13 | 1,200.7 | 0.59 | 5,546.3 | 345.81 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,218.9 | 57.17 | 1,08,937.31 | 474 | 0.99 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Non Executive Director
Vinay Ramakant Sapte
Non Executive Director
Maneesh R Sapte
Whole-time Director
Y N Bhaskara Rao
Non Executive Director
Rashmi V Sapte
Independent Director
PRAVIN M. HEGDE
Independent Director
Ajit G Jamkhandikar
Company Sec. & Compli. Officer
Urvashi Bhatia
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Phaarmasia Ltd
Summary
Incorporated in 1981, Phaarmasia Limited (unit-I) is the part of the Maneesh Pharmaceutical Limited, with its headquarters and marketing office in Mumbai. M/s Phaarmasia Limited Unit-II was established in 1993-94. The Company is engaged in manufacturing and marketing of Oral contraceptive tablets with various therapeutic dosage combinations along with iron tablets for Ministry of Health & Family Welfare and for Exports. The plant is situated in a hygienic environment; free from dust, smoke, chemical & biological emission. Phaarmasia Ltd. Is an independent State-of-the-art-manufacturing unit having manufacturing facility of international standards with manufacturing capacity of more than 30 million units per annum. During the year 2000, the company became a Sick Industrial Company under SICA and therefore the same was referred to the BIFR.During past a few decades, Phaarmasia mastered and manufactured wide range of Pharmaceutical Formulations at a WHO-GMPcertified and ISO 9001-certified manufacturing facility.
Read More
What is the Phaarmasia Ltd share price today?
The Phaarmasia Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹30.88 today.
What is the Market Cap of Phaarmasia Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Phaarmasia Ltd is ₹21.09 Cr. as of 10 Jun ‘25
What is the PE and PB ratio of Phaarmasia Ltd?
The PE and PB ratios of Phaarmasia Ltd is 0 and 4.69 as of 10 Jun ‘25
What is the 52 Week High and Low of Phaarmasia Ltd?
The 52-week high/low is the highest and lowest price at which a Phaarmasia Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Phaarmasia Ltd is ₹23.6 and ₹64.75 as of 10 Jun ‘25
What is the CAGR of Phaarmasia Ltd?
Phaarmasia Ltd's CAGR for 5 Years at 10.07%, 3 Years at 11.11%, 1 Year at -20.08%, 6 Month at -37.59%, 3 Month at 2.11% and 1 Month at -2.35%.
What is the shareholding pattern of Phaarmasia Ltd?
The shareholding pattern of Phaarmasia Ltd is as follows:
Promoters - 73.51 %
Institutions - 0.06 %
Public - 26.43 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.